RxDoctor Payments Data

Emilee Hayden

Adult Health · Cincinnati, OHNPI 1528572575

Payments from drug & device makers

$530in general payments, 2019–2025

Across 26 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$176
  • Astellas Pharma US Inc$130
  • Novo Nordisk$64
  • Daiichi Sankyo Inc.$32
  • Exact Sciences$32
  • Lilly USA, LLC$32
  • plus $63 from 3 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$530 in reported general payments places this provider in the 55th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$33,445
Medicare patients
229
Services billed
486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$29,807
JanuviaSitagliptin Phosphate20$20,945
JardianceEmpagliflozin14$10,462
SymbicortBudesonide/Formoterol Fumarate18$4,558
Atorvastatin Calcium279$2,184
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$1,909
Albuterol Sulfate HfaAlbuterol Sulfate75$1,776
Levothyroxine Sodium208$1,525
Duloxetine Hcl48$1,272
Gabapentin97$1,241
Omeprazole103$1,077
Metoprolol Succinate62$1,024
Amlodipine Besylate165$856
SynthroidLevothyroxine Sodium31$853
Bupropion XlBupropion Hcl29$838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaSymbicort$176$4,55818 claims
AbbVieSynthroid$29$85331 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,184 adult health providers in Ohio.

Other adult health in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →